Egyptian Drug Authority · Egypt
DEA-EG-2022-0031
Tier 1 · Regulator-publishedUnclassifiedPublic warningStatus · active
- Issuing authority
- Egyptian Drug Authority (EDA)
- Authority reference
- Periodic report no.(31) For 2022
- Date issued
- 06 Nov 2022
- Recorded by us
- 2026-09-06 19:45:29 UTC
- Product
- Linezolid 600
- INN / active substance
- Not stated by the issuing authority
- Dosage form
- Not stated by the issuing authority
- Strength
- Not stated by the issuing authority
- Manufacturer
- Not stated by the issuing authority
- Manufacturer country
- Not stated by the issuing authority
- MAH or importer
- Not stated by the issuing authority
- Batch numbers
- Not published with the notice
- Expiry dates
- Not published with the notice
- Action type
- Public warning
- Classification
- Not stated by the issuing authority
- Indicative severity
- Not assessed by Drug Eye Africa
- Defect category
- Not stated by the issuing authority
- Product type
- Not stated by the issuing authority
- ATC code
- Not stated by the issuing authority
- Affected markets
- Egypt — no market beyond the issuing country was named on the notice
- Cross-border event
- Not linked to a cross-border event
- Notice text
- @egyptiandrugauthority
www.edaegypt.gov.eg
15301
٦ نوفمبر٢٢٠٢
يتم ضبط وتحريز العبوات المقلدة من المستحضر التالي:
حيث يمكن التفرقة ظاهرياً بين العبوات الأصلية والعبوات المقلدة
للمستحضر المذكور -وذلك بناءً على ماورد إلينا من الشركة صاحبة
المستحضر- كالآتي:
منشور
غش تجاري
Linezolid 600
7 film coated tablets
تشغيله رقم
مدون على العبوة تصنيع: جلوبال نابى للأدوية
@egyptiandrugauthority
www.edaegypt.gov.eg
15301
Linezolid 600
7 film coated tablets
H18113 - H18116تشغيله رقم
مدون على العبوة تصنيع: جلوبال نابى للأدوية
@egyptiandrugauthority
www.edaegypt.gov.eg
15301
Linezolid 600
7 film coated tablets
H18113 - H18116تشغيله رقم
مدون على العبوة تصنيع: جلوبال نابى للأدويةOriginal language: ar
- Notice text in English
- Trade-counterfeiting circular, November 2022. Counterfeit packs of the following product are to be impounded and seized: Linezolid 600, 7 film coated tablets, made by Global Napi Pharmaceuticals, with the batch number printed on the pack. Genuine and counterfeit packs can be told apart by sight, on the basis of what the company that owns the product has reported to the Authority.Machine translation, produced by Drug Eye Africa and not checked by the issuing authority. The authority stated only the text above it.
- Status
- Active
- Superseded by
- Not superseded. This is the current version.
- Version
- 1
Where this record came from, and what is held to show it.
- Copy of the source
- Taken and held by Drug Eye Africa, so the record survives the link above being moved or withdrawn. Not yet published at an address you can open.Ask us for it and check it against the fingerprint below.
- Fingerprint
- e71ce48f42070b316e69c4352dee8869997fb506d66b32a768b4ab6c5f598a04SHA-256 of the copy held. Any file that produces this number is that copy, byte for byte; any file that does not is a different document.
- Copy taken
- 2026-09-06 20:36:25 UTC
Cite this record
Drug Eye Africa (2022). DEA-EG-2022-0031: Linezolid 600 — Public warning, Egyptian Drug Authority. Register of African Regulatory Actions. https://drugeyeafrica.org/register/notice/eg/2022/dea-eg-2022-0031Version history
—No version history recorded for this record.
—Corrections appear here and in the site-wide log. Records are superseded, never deleted.
Verification
Tier 1 — Published by the issuing regulator on its own channel and captured by Drug Eye Africa, with the source document archived.
Indexing
This record is indexable: it is dated, names a product, and carries either a batch number or a stated reason.